Royal Society of Chemistry, Molecular BioSystems, 5(2), p. 240
DOI: 10.1039/b518044a
Full text: Unavailable
A ligand Fit shap-directed docking methodology was used to identify the best position at which the melanoma-derived MHC class-I-HLA-A2-binding antigenic peptide ELAGIGILTV could be modified by attaching a small molecule capable of fitting at the interface of complementary determining regional (CDR) loops of a T-cell receptor (TCR)whilie triggering T-cell responses.